BridgeCalm vs. Wysa vs. Ash: Which AI Companion Works With Your Therapist?

The mental health AI space has exploded. If you're looking for an app to supplement therapy—or just want support between sessions—you've probably seen ads for Wysa, Ash, BridgeCalm, and a half-dozen others. They all promise to help you practice skills, track your mood, and reduce anxiety.

But here's the truth: they're not the same thing.

This comparison is for both patients and therapists. If you're a therapist wondering which platform could actually integrate with your practice, you need different information than a patient just looking for daily support. We'll cover both.

---

What Each Platform Actually Is

Wysa: The Enterprise Hybrid Model

Wysa has been around since 2015 and serves 7+ million users across 95 countries. In March 2025, Wysa acquired April Health, a digital therapeutics company offering asynchronous messaging with licensed therapists—a significant move toward the "human + AI" model.

What you get with Wysa:

• 150+ therapeutic exercises (CBT, DBT, ACT, mindfulness)
• Daily mood tracking and journaling
• Meditation and sleep guidance
• Wysa Copilot (2024-2025 launch): therapist-prescribed digital tools + async messaging from a licensed therapist
• Multilingual support (39 languages)
• Enterprise/CoCM (Collaborative Care Model) partnerships with health systems and insurance plans

The evidence base: Wysa has genuine clinical backing. The NHS-funded clinical trial at Imperial College London (published results, 2023–2024) showed improvements in mood, sleep quality, and overall wellbeing. In 2025, Wysa received FDA Breakthrough Device Designation for musculoskeletal pain combined with depression and anxiety—one of the first AI mental health tools to achieve this. That's not marketing fluff; it's meaningful regulatory recognition.

Therapist integration (limited, but growing): Wysa Copilot is designed for therapists to prescribe specific digital tools and asynchronously message patients. If you work in a large health system or insurance network, Wysa might already be an option. Individual therapists can't currently integrate Wysa directly into their practice flow the way BridgeCalm is building it.

Pricing: Free app with limited features; premium tiers start around $8/month. Enterprise/Copilot pricing varies by organization.

---

Ash: High Funding, Regulatory Headwinds

Ash, launched by Slingshot AI in July 2025, raised $93 million from heavyweight investors (Radical Ventures, Forerunner Ventures) and went to market fast. CEO Derrick Hull is a former Talkspace clinical R&D lead, so the team has therapy app experience.

What you get with Ash:

• Conversational AI trained on the largest behavioral health datasets available (CBT, DBT, ACT, psychodynamic, motivational interviewing)
• Free iOS/Android app at launch
• Personalized response to mood and life situations
• No paywall announced yet (beta phase)

The evidence base: Here's where Ash faces challenges. The app started with 50,000 beta users, but no published randomized controlled trial (RCT) yet. For comparison, Flourish published its RCT in NEJM AI and dropped its paywall afterward. Wysa has NHS-funded data. Ash has funding and clinical expertise, but not yet published efficacy data.

Therapist integration: None. Ash is a pure consumer app with no dashboard, messaging, or outcome sharing for therapists. If your therapist asks "Can you use Ash and share your progress with me?", the honest answer is: not yet, and it's unclear if that's in the roadmap.

Regulatory reality (important): Ash faced significant headwinds in early 2026. The app was pulled from the UK market in January 2026 over regulatory concerns about positioning as "AI therapy" without sufficient evidence. The UK's MHRA has stricter rules around mental health claims than the US FDA. Ash is continuing in the US and Canada, but this signals that regulators are scrutinizing how these apps frame themselves—more on that below.

Pricing: Free to start, but likely freemium in the long term.

---

BridgeCalm: The Therapist-Connected Model

BridgeCalm launched in 2025 with a different bet: what if the AI companion was designed specifically to work with your therapist rather than replace or bypass them?

What you get with BridgeCalm:

• Jann: Your AI wellness companion (not a "therapist"—we're deliberate about this distinction)
• 6 conversation styles (The Coach/CBT, The Anchor/DBT, The Explorer/ACT, The Mirror/Psychodynamic, The Ally/Humanistic, The Strategist/Solution-Focused)
• Daily 10-second mood check-ins with visual mood timeline
• Skill tree progression (6 skills × 5 levels: Thought Records, Box Breathing, STOP Technique, Values Clarity, Body Scan, Cognitive Defusion)
• Streak system with freeze option (for realistic streaks during hard weeks)
• Therapist-assigned homework with "How do I do this?" guides and difficulty reporting
• Therapist dashboard with 15+ features: patient outcomes, PHQ-9/GAD-7 tracking, pre-session briefs, custom homework assignment with Jann, crisis detection

The positioning (regulatory-aware): BridgeCalm explicitly does not claim to be therapy. Jann is a "wellness companion" or "AI-guided wellness practice tool." This isn't hedging—it's intentional design. You use BridgeCalm with your therapist, not instead of your therapist. The brief you export at week's end is for your therapist to read, not a replacement for the session.

Therapist integration (built-in): This is the differentiator. Individual therapists (solo practitioners, small groups, clinics) can use BridgeCalm's portal today. You log in, see your patients' mood trends, PHQ-9 scores, which homework they've completed, and which tasks they flagged as hard. You can assign homework from the library or have Jann generate a custom exercise tailored to what the patient shared. You generate a pre-session brief 24 hours before the appointment. The data syncs.

Evidence base (in progress): BridgeCalm is early; there's no published RCT yet. However, the clinical advisory board includes CBT/DBT specialists, and the design is grounded in existing evidence for skill practice and mood tracking. RCT planning is underway.

Pricing:

• Patient: $9.99/month (or free with therapist assignment)
• Therapist: $29/month per patient seat (individuals/small practices)

---

How They Compare: The Matrix

| Feature | Wysa | Ash | BridgeCalm | |---------|------|-----|-----------| | Therapist Dashboard | Limited (Copilot for enterprise) | None | Yes, built-in | | Individual Therapist Integration | No | No | Yes | | Published Clinical Trial | Yes (NHS Imperial College) | No (yet) | In progress | | FDA/Regulatory Recognition | Breakthrough Device (2025) | Pulled from UK (Jan 2026) | Proactive compliance | | Skill Progression System | Exercises only | Conversation-based | Structured skill tree (6 skills, 5 levels) | | Conversation Styles/Modalities | Implicit in exercises | Yes (CBT, DBT, ACT, etc.) | Explicit (6 styles, pick 2) | | Homework Assignment | Via Copilot (enterprise) | No | Yes, from therapist | | Free Option | Yes, limited | Yes | Yes, if assigned by therapist | | Consumer Price | ~$8/month | Free (for now) | $9.99/month | | Multi-Language | 39 languages | English primarily | English (expanding) | | Crisis Routing | Yes | Yes | Yes |

---

Who Each One Is Actually Built For

Choose Wysa if:

• You're in a large health system, insurance network, or employer offering it (often covered)
• You want an established app with published clinical evidence
• You prefer a structured exercise library over conversational AI
• You're open to asynchronous therapist messaging if your system offers Copilot
• You want to practice skills independently without therapist oversight

Choose Ash if:

• You want a free, conversational AI that mimics therapy dialogue
• You're willing to wait for published efficacy data (or contribute to it as a beta user)
• You don't need therapist integration
• You're in the US or Canada (UK availability is limited)
• You want cutting-edge AI without regulatory constraints

The honest caveat: Ash's positioning as "AI therapy" creates regulatory risk. If you're a patient, understand that "AI therapy" is not the same as therapy with a licensed clinician. The UK pullback in January 2026 shows regulators are tightening language around these claims. Ash may adjust positioning or face further restrictions.

Choose BridgeCalm if:

• You already see a therapist and want to share progress between sessions
• Your therapist is open to using a patient-facing app with a dashboard
• You want accountability from your therapist without replacing the relationship
• You like the idea of structured skill practice (Thought Records, breathing exercises) with AI guidance
• You want homework from your therapist with built-in guides
• You're comfortable with a newer platform that's still building its evidence base

---

The Real Question: AI Supplement or AI Replacement?

Here's where this gets philosophical.

Wysa and Ash are designed to give you mental health support whether or not you have a therapist. That's valuable—many people can't access therapy due to cost, geography, or waitlists. An AI companion is better than nothing.

BridgeCalm assumes you have a therapist (or want one) and is built to extend the work you do together. It's not trying to replace therapy; it's trying to fill the gap between sessions. The therapist dashboard exists because the assumption is: the therapist should be in the loop.

Both models are legitimate. But they're asking different questions:

• Wysa/Ash: "How can AI provide mental health support to anyone, anywhere?"
• BridgeCalm: "How can AI help therapy work better by keeping patients practicing between sessions?"

If you have a therapist, the second question is worth asking. If you don't, the first one might be more relevant.

---

Evidence & Regulatory Landscape

As of March 2026, here's the state of play:

Published evidence:

• Wysa: NHS trial positive; FDA Breakthrough Device designation (2025)
• Ash: No published RCT; $93M in venture funding (not clinical evidence)
• Flourish: Published RCT in NEJM AI; subsequently dropped paywall
• BridgeCalm: No published trial yet; RCT in planning

Regulatory positioning:

• Wysa: FDA-aware; working within digital therapeutics framework
• Ash: Pulled from UK market (Jan 2026) over "AI therapy" language; continuing in US/Canada with regulatory risk
• BridgeCalm: Deliberate positioning below "therapy" threshold; "wellness companion" language; proactive HIPAA/NIST alignment

The takeaway: regulatory scrutiny is tightening. Apps claiming "therapy" without evidence or appropriate disclaimers are facing pushback from MHRA (UK), and likely FDA/state regulators are next. If you're choosing between platforms, credibility and regulatory transparency matter.

---

The Bottom Line

| If you're a patient: | If you're a therapist: | |---|---| | Already seeing a therapist? BridgeCalm or Wysa (therapist decides). | Want to integrate AI homework? BridgeCalm's dashboard makes this feasible for individual practices. | | No therapist? Wysa (published evidence) or Ash (free, cutting-edge AI). | Work in a health system? Wysa/April Health Copilot might already be available. | | Want transparency on safety? All three route crises to 988/741741, but Wysa and BridgeCalm are more explicit about limitations. | Want your patients to share progress? BridgeCalm exports a therapist-facing brief; Wysa requires CoCM partnership. |

---

What to Ask Your Therapist

If you're considering one of these apps:

1. "Have you used this platform with other patients? What did you observe?"
2. "Can you see my progress / homework completion in the app?" (Some can, some can't.)
3. "How does this fit into our treatment plan?" (It should be intentional, not just "use this app.")
4. "Will this replace or supplement our sessions?" (Critical distinction.)
5. "Is this crisis-safe?" (All three route to 988/741741, but confirm your therapist knows the app's limits.)

---

The Honest Conclusion

Each of these platforms is trying to solve a real problem: therapy is expensive, waitlists are long, and the gap between sessions is real. They're taking different approaches.

Wysa is winning on evidence and enterprise scale. It's the "safe choice" for health systems.

Ash is technically impressive but carrying regulatory risk. It's a bet on AI conversation depth over therapist integration.

BridgeCalm is betting that therapist integration is the missing piece—that AI works better with your clinician, not instead of them.

We built BridgeCalm because we believe that last statement. But if Wysa's approach resonates more with you, or if Ash's AI feels more natural in conversation, that's okay too. The best app is the one you'll actually use, in partnership with your therapist.

---

Crisis Resources

If you're in crisis, AI can't help. Please reach out:

• 988 Suicide & Crisis Lifeline — Call or text 988 (US)
• Crisis Text Line — Text HOME to 741741
• International Association for Suicide Prevention — https://www.iasp.info/resources/Crisis_Centres/

Your therapist, a trusted person, or emergency services are the right choice in crisis. Always.

---

Want BridgeCalm to work with your therapist? Join our waitlist for early access to the therapist portal.